EMEA (Europe, Middle East and Africa) Preventive Asthma Drugs Market Report 2017

October 2017 | 126 pages | ID: E064C2187FBPEN
QYResearch

Abstracts

In this report, the EMEA Preventive Asthma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Preventive Asthma Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Preventive Asthma Drugs market competition by top manufacturers/players, with Preventive Asthma Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca
• F. Hoffmann-La Roche
• GlaxoSmithKline'
• Merck
• Novartis'
• Abbott
• Amgen
• AptarGroup
• Biotest
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cytos
• Dainippon Sumitomo
• Medicinova
• Mylan
• Novartis
• Orchid Chemicals and Pharmaceuticals
• Pfizer
• Rottapharm Madaus
• Skyepharma
• Sosei
• Sunovion
• Teva Pharmaceutical'
• Theravance
• Vectura '

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Immunosuppressants'
• Leukotriene antagonists
• Mast cell stabilizers
• Corticosteroids
• Combination of LABA/ ICS

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Preventive Asthma Drugs for each application, including

• Children
• Adult

Contents

EMEA (Europe, Middle East and Africa) Preventive Asthma Drugs Market Report 2017

1 PREVENTIVE ASTHMA DRUGS OVERVIEW

1.1 Product Overview and Scope of Preventive Asthma Drugs
1.2 Classification of Preventive Asthma Drugs
  1.2.1 EMEA Preventive Asthma Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Preventive Asthma Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Immunosuppressants?
  1.2.4 Leukotriene antagonists
  1.2.5 Mast cell stabilizers
  1.2.6 Corticosteroids
  1.2.7 Combination of LABA/ ICS
1.3 EMEA Preventive Asthma Drugs Market by Application/End Users
  1.3.1 EMEA Preventive Asthma Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Children
  1.3.3 Adult
1.4 EMEA Preventive Asthma Drugs Market by Region
  1.4.1 EMEA Preventive Asthma Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Preventive Asthma Drugs (2012-2022)
  1.5.1 EMEA Preventive Asthma Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Preventive Asthma Drugs Revenue and Growth Rate (2012-2022)

2 EMEA PREVENTIVE ASTHMA DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Preventive Asthma Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Preventive Asthma Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Preventive Asthma Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Preventive Asthma Drugs Sale Price by Players (2012-2017)
2.2 EMEA Preventive Asthma Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Preventive Asthma Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Preventive Asthma Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Preventive Asthma Drugs Sale Price by Type (2012-2017)
2.3 EMEA Preventive Asthma Drugs (Volume) by Application
2.4 EMEA Preventive Asthma Drugs (Volume and Value) by Region
  2.4.1 EMEA Preventive Asthma Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Preventive Asthma Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Preventive Asthma Drugs Sales Price by Region (2012-2017)

3 EUROPE PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Preventive Asthma Drugs Sales and Value (2012-2017)
  3.1.1 Europe Preventive Asthma Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Preventive Asthma Drugs Sales and Market Share by Type
3.3 Europe Preventive Asthma Drugs Sales and Market Share by Application
3.4 Europe Preventive Asthma Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Preventive Asthma Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Preventive Asthma Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Preventive Asthma Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Preventive Asthma Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Preventive Asthma Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Preventive Asthma Drugs Sales and Market Share by Type
4.3 Middle East Preventive Asthma Drugs Sales and Market Share by Application
4.4 Middle East Preventive Asthma Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Preventive Asthma Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Preventive Asthma Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Preventive Asthma Drugs Sales and Growth Rate (2012-2017)

5 AFRICA PREVENTIVE ASTHMA DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Preventive Asthma Drugs Sales and Value (2012-2017)
  5.1.1 Africa Preventive Asthma Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Preventive Asthma Drugs Sales and Market Share by Type
5.3 Africa Preventive Asthma Drugs Sales and Market Share by Application
5.4 Africa Preventive Asthma Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Preventive Asthma Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Preventive Asthma Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Preventive Asthma Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Preventive Asthma Drugs Sales and Growth Rate (2012-2017)

6 EMEA PREVENTIVE ASTHMA DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline?
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline? Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis?
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis? Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Abbott
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Abbott Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amgen
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amgen Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AptarGroup
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AptarGroup Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biotest
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biotest Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Boehringer Ingelheim
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Preventive Asthma Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Boehringer Ingelheim Preventive Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Chiesi Farmaceutici
6.12 Cytos
6.13 Dainippon Sumitomo
6.14 Medicinova
6.15 Mylan
6.16 Novartis
6.17 Orchid Chemicals and Pharmaceuticals
6.18 Pfizer
6.19 Rottapharm Madaus
6.20 Skyepharma
6.21 Sosei
6.22 Sunovion
6.23 Teva Pharmaceutical?
6.24 Theravance
6.25 Vectura ?

7 PREVENTIVE ASTHMA DRUGS MANUFACTURING COST ANALYSIS

7.1 Preventive Asthma Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Preventive Asthma Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Preventive Asthma Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Preventive Asthma Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PREVENTIVE ASTHMA DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Preventive Asthma Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Preventive Asthma Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Preventive Asthma Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Preventive Asthma Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Preventive Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Preventive Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Preventive Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Preventive Asthma Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Preventive Asthma Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Preventive Asthma Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Preventive Asthma Drugs
Figure EMEA Preventive Asthma Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Preventive Asthma Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunosuppressants? Product Picture
Figure Leukotriene antagonists Product Picture
Figure Mast cell stabilizers Product Picture
Figure Corticosteroids Product Picture
Figure Combination of LABA/ ICS Product Picture
Figure EMEA Preventive Asthma Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Preventive Asthma Drugs by Application in 2016
Figure Children Examples
Figure Adult Examples
Figure EMEA Preventive Asthma Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Preventive Asthma Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Preventive Asthma Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Preventive Asthma Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Preventive Asthma Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Preventive Asthma Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Preventive Asthma Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Preventive Asthma Drugs Sales Share by Players (2012-2017)
Figure 2016 Preventive Asthma Drugs Sales Share by Players
Figure 2017 Preventive Asthma Drugs Sales Share by Players
Figure EMEA Preventive Asthma Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Preventive Asthma Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Preventive Asthma Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Preventive Asthma Drugs Revenue Share by Players
Table 2017 EMEA Preventive Asthma Drugs Revenue Share by Players
Table EMEA Preventive Asthma Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Preventive Asthma Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Preventive Asthma Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Preventive Asthma Drugs by Type (2012-2017)
Figure EMEA Preventive Asthma Drugs Sales Market Share by Type (2012-2017)
Table EMEA Preventive Asthma Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Preventive Asthma Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Preventive Asthma Drugs by Type in 2016
Table EMEA Preventive Asthma Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Preventive Asthma Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Preventive Asthma Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Preventive Asthma Drugs by Application (2012-2017)
Figure EMEA Preventive Asthma Drugs Sales Market Share by Application in 2016
Table EMEA Preventive Asthma Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Preventive Asthma Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Preventive Asthma Drugs by Region (2012-2017)
Figure EMEA Preventive Asthma Drugs Sales Market Share in 2016
Table EMEA Preventive Asthma Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Preventive Asthma Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Preventive Asthma Drugs by Region (2012-2017)
Figure EMEA Preventive Asthma Drugs Revenue Market Share Regions in 2016
Table EMEA Preventive Asthma Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Preventive Asthma Drugs Revenue and Growth Rate (2012-2017)
Table Europe Preventive Asthma Drugs Sales (K Units) by Type (2012-2017)
Table Europe Preventive Asthma Drugs Market Share by Type (2012-2017)
Figure Europe Preventive Asthma Drugs Market Share by Type in 2016
Table Europe Preventive Asthma Drugs Sales (K Units) by Application (2012-2017)
Table Europe Preventive Asthma Drugs Market Share by Application (2012-2017)
Figure Europe Preventive Asthma Drugs Market Share by Application in 2016
Table Europe Preventive Asthma Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Preventive Asthma Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Preventive Asthma Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Preventive Asthma Drugs Sales Market Share by Countries in 2016
Table Europe Preventive Asthma Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Preventive Asthma Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Preventive Asthma Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Preventive Asthma Drugs Revenue Market Share by Countries in 2016
Figure Germany Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Preventive Asthma Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Preventive Asthma Drugs Market Share by Type (2012-2017)
Figure Middle East Preventive Asthma Drugs Market Share by Type (2012-2017)
Table Middle East Preventive Asthma Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Preventive Asthma Drugs Market Share by Applications (2012-2017)
Figure Middle East Preventive Asthma Drugs Sales Market Share by Application in 2016
Table Middle East Preventive Asthma Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Preventive Asthma Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Preventive Asthma Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Preventive Asthma Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Preventive Asthma Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Preventive Asthma Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Preventive Asthma Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Preventive Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Preventive Asthma Drugs Sales (K Units) by Type (2012-2017)
Table Africa Preventive Asthma Drugs Sales Market Share by Type (2012-2017)
Figure Africa Preventive Asthma Drugs Sales Market Share by Type (2012-2017)
Figure Africa Preventive Asthma Drugs Sales Market Share by Type in 2016
Table Africa Preventive Asthma Drugs Sales (K Units) by Application (2012-2017)
Table Africa Preventive Asthma Drugs Sales Market Share by Application (2012-2017)
Figure Africa Preventive Asthma Drugs Sales Market Share by Application (2012-2017)
Table Africa Preventive Asthma Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Preventive Asthma Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Preventive Asthma Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Preventive Asthma Drugs Sales Market Share by Countries in 2016
Table Africa Preventive Asthma Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Preventive Asthma Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Preventive Asthma Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Preventive Asthma Drugs Revenue Market Share by Countries in 2016
Figure South Africa Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Table AstraZeneca Preventive Asthma Drugs Basic Information List
Table AstraZeneca Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Preventive Asthma Drugs Basic Information List
Table F. Hoffmann-La Roche Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline? Preventive Asthma Drugs Basic Information List
Table GlaxoSmithKline? Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline? Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline? Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline? Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck Preventive Asthma Drugs Basic Information List
Table Merck Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis? Preventive Asthma Drugs Basic Information List
Table Novartis? Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis? Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis? Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis? Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table Abbott Preventive Asthma Drugs Basic Information List
Table Abbott Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table Amgen Preventive Asthma Drugs Basic Information List
Table Amgen Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure Amgen Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table AptarGroup Preventive Asthma Drugs Basic Information List
Table AptarGroup Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AptarGroup Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AptarGroup Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure AptarGroup Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table Biotest Preventive Asthma Drugs Basic Information List
Table Biotest Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotest Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Biotest Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure Biotest Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Preventive Asthma Drugs Basic Information List
Table Boehringer Ingelheim Preventive Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Preventive Asthma Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Preventive Asthma Drugs Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Preventive Asthma Drugs Revenue Market Share in EMEA (2012-2017)
Table Chiesi Farmaceutici Preventive Asthma Drugs Basic Information List
Table Cytos Preventive Asthma Drugs Basic Information List
Table Dainippon Sumitomo Preventive Asthma Drugs Basic Information List
Table Medicinova Preventive Asthma Drugs Basic Information List
Table Mylan Preventive Asthma Drugs Basic Information List
Table Novartis Preventive Asthma Drugs Basic Information List
Table Orchid Chemicals and Pharmaceuticals Preventive Asthma Drugs Basic Information List
Table Pfizer Preventive Asthma Drugs Basic Information List
Table Rottapharm Madaus Preventive Asthma Drugs Basic Information List
Table Skyepharma Preventive Asthma Drugs Basic Information List
Table Sosei Preventive Asthma Drugs Basic Information List
Table Sunovion Preventive Asthma Drugs Basic Information List
Table Teva Pharmaceutical? Preventive Asthma Drugs Basic Information List
Table Theravance Preventive Asthma Drugs Basic Information List
Table Vectura ? Preventive Asthma Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Preventive Asthma Drugs
Figure Manufacturing Process Analysis of Preventive Asthma Drugs
Figure Preventive Asthma Drugs Industrial Chain Analysis
Table Raw Materials Sources of Preventive Asthma Drugs Major Manufacturers in 2016
Table Major Buyers of Preventive Asthma Drugs
Table Distributors/Traders List
Figure EMEA Preventive Asthma Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Preventive Asthma Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Preventive Asthma Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Preventive Asthma Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Preventive Asthma Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Preventive Asthma Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Preventive Asthma Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Preventive Asthma Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Preventive Asthma Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Preventive Asthma Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Preventive Asthma Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Preventive Asthma Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Preventive Asthma Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Preventive Asthma Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Preventive Asthma Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Preventive Asthma Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Preventive Asthma Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Preventive Asthma Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Preventive Asthma Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Preventive Asthma Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Preventive Asthma Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Preventive Asthma Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Preventive Asthma Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources